CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart...
Phase 2
Milano, Italy and 64 other locations
This study is testing a potential new medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis.The study ...
Phase 2
Pavia, PV, Italy and 32 other locations
This study will evaluate the safety of the Cardiovalve Transfemoral Mitral Valve System with its associated procedure, and observe the device perform...
Milano, Italy and 10 other locations
This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe ...
Phase 2
Pavia, PV, Italy and 30 other locations
Evaluation of TAVR using the NAVITOR valve in a Global Investigation.
Milan, Italy and 37 other locations
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Milan, Italy and 186 other locations
The purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of co...
Milan, San Donato Milanese, Italy and 10 other locations
This is a Phase 2, multicenter, double-blind, sponsor unblinded, placebo-controlled, single-dose clinical study of CRD-4730 to evaluate the safety, t...
Phase 2
Pavia, Lombardia, Italy and 10 other locations
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...
Milano, MI, Italy and 72 other locations
2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart...
San Donato Milanese, Italy and 131 other locations
Clinical trials
Research sites
Resources
Legal